Search Patents
  • Patent number: 7618802
    Abstract: The present invention provides a cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles. Also provided are methods of making the compositions of this invention and methods of using the compositions as immunogens and/or vaccines and/or to express heterologous nucleic acids.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: November 17, 2009
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Ralph S. Baric, Rhonda Roberts, Boyd Yount, Kristopher M. Curtis
  • Publication number: 20020177230
    Abstract: Full-length, functionally intact genomes or chromosomes are directionally assembled with partial cDNA or DNA subclones of a genome. This approach facilitates the reconstruction of genomes and chromosomes in vitro for reintroduction into a living host, and allows the selected mutagenesis and genetic manipulation of sequences in vitro prior to reassembly into a full length genome molecule for reintroduction into the same or different host. This approach also provides an alternative to recombination-mediated techniques to manipulate the genomes of higher plants and animals as well as bacteria and viruses.
    Type: Application
    Filed: May 21, 2001
    Publication date: November 28, 2002
    Inventors: Ralph S. Baric, Boyd Yount
  • Publication number: 20140271712
    Abstract: The present invention provides methods and compositions comprising a chimeric norovirus capsid protein comprising a norovirus VP1 major capsid protein backbone comprising a norovirus epitope selected from the group consisting of: a) Epitope A; b) Epitope B; c) Epitope C; d) Epitope D; e) Epitope E; f) Epitope F; and g) any combination of (a) through (f) above, wherein the norovirus epitope is from a norovirus strain that is different from the norovirus VP1 major capsid protein backbone.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Ralph Steven Baric, Lisa Chon Lindesmith, Kari Moore Debbink, Eric Francis Donaldson, Jesica Anne Swanstrom
  • Patent number: 7279327
    Abstract: A helper cell for producing an infectious, replication defective, coronavirus (or more generally nidovirus) particle cell comprises (a) a nidovirus permissive cell; (b) a nidovirus replicon RNA comprising the nidovirus packaging signal and a heterologous RNA sequence, wherein the replicon RNA further lacks a sequence encoding at least one nidovirus structural protein; and (c) at least one separate helper RNA encoding the at least one structural protein absent from the replicon RNA, the helper RNA(s) lacking the nidovirus packaging signal. The combined expression of the replicon RNA and the helper RNA in the nidovirus permissive cell produces an assembled nidovirus particle which comprises the heterologous RNA sequence, is able to infect a cell, and is unable to complete viral replication in the absence of the helper RNA due to the absence of the structural protein coding sequence in the packaged replicon.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: October 9, 2007
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Kristopher M. Curtis, Boyd Yount, Ralph S. Baric